This site features recent Bon Secours Richmond information of specific interest to our physicians. We will post information about events and seminars that may be of interest to our physicians and their patients, as well.
Physician Computing
A physician Internet link to forms on line and educational and informational utilities to access applications on the Bon Secours Richmond network.
IRB Protocols
Find out about for Bon Secours Richmond Health System IRB Approved Protocols that are actively recruiting subjects.
IRB Submission Forms
BSRHS IRB submission forms, submission deadlines, and meeting dates and locations.
Physician Computing
Bon Secours Physician IS Services
The Physician IS Web Page is an on-line reference center for physicians interested in Information Technology-assisted patient care resources.
The Bon Secours Richmond Chief Information Officer (CIO) page posts quarterly updates on the strategic direction and mission for Physician’s IT resources.
There is a catalog of applications to facilitate understanding of applications Bon Secours has to offer.
Forms on line will allow physicians or their office staff to fill out a security form requesting access to an application(s), request a vpn for remote access, or fill out a new office profile for staff to gain access to the hospital information system for the first time.
Technical requirements, Quick Start Guides, FAQs and Tutorials help the physician get started using applications or answer basic questions as they begin navigating new pathways.
Need to reset a forgotten password or have questions regarding an application or filling out an online form, please call our Information Services Help Desk at 627-5070.
BSR MDNet
Get access to Patient Care Data for Physicians >>
Minimum Requirements needed for you to access BSRMD Net:
Pentium class PC (IBM Compatible) with 16 MB RAM, 200 mhz processor; Windows 95/98/NT or higher; 200 MB disk space on hard drive for browser and a 56K modem or a cable/ADSL modem with an Internet service Provider (AOL, Erols, Comcast, RoadRunner, etc.) Browser required: Netscape Navigator 4.03 or higher; Microsoft Internet Explorer 4.0 or higher. Browsers must have 128-bit encryption.
MAC Power PC 16 MB RAM, Mac OS 7.5 or higher; Internet Explorer 4.03 or higher or Netscape Navigator 4.03 or higher for Macintosh, both with 128-bit encryption.
To determine the version of your IE browser: Open the browser. Choose "Help." From the Drop-down menu, choose: "About Internet Explorer." A separate display will give you "cipher strength." If it does not say, "128 bit," click on "Update Information" and follow the prompts to download the appropriate encryption software. Or, go to the Download Center.
To determine the version of Netscape Navigator: Open the browser. Choose "Help." From the dropdown menu, select, "About Netscape Communicator. If your screen does not state "This version supports U.S. security with RSA Public Key Cryptography, MD2, MD5, RC5ÑCBC, RC4, DES-CBC, DES-EDE3-CBC, you will need to download the 128-bit version from www.netscape.com.
Email your request to be setup for BSRMD Net to medicalstaffanalyst@bshsi.com.
BSRHS IRB Approved Protocols
Radiation Therapy Protocols
Contact: Judy Chin, MD, 266-7762
Ann Kaplan, RN, phone-287-7418, Beeper 759-4138
| Name |
Title |
Stage/Grade |
| Breast |
|
|
NSABP
B-39 |
A Randomized Phase III Study of Conventional Whold Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer |
0, I, II |
Contact: George A. Trivette, MD, 281-8350
Ann Kaplan, RN, phone-287-7418, Beeper 759-4138
RTOG
O214
|
A Phase III Comparison of Prophylactic Cranial Irradiation
Versus Observation In Patients With Locally Advanced
Non-Small Cell Lung Cancer
|
IIIA or IIIB after completing definitive therapy
|
^ Back to top
Oncology Protocols
Contact: Sharon Goble, MD, 288-7159
Kim Sydnor, phone- 288-7159
CALGB
40101/
CTSU
40101 |
Cyclophosphamide and Doxorubicin (CA) (4 vs 6 Cycles)
Versus Paclitaxel (12 Weeks vs 18 Weeks) as Adjuvant
Therapy for Women with Node-Negative Breast Cancer:
a 2x2 Factorial Phase III Randomized Study |
Contact: M. Kelly Hagan, MD, 288-7159
Kim Sydnor, phone- 288-7159
TAILORx
Trial |
Program for the Assessment of Clinical Cancer Tests (PACCT-s):
Trial Assigning Individualized Options for Treatment: The TAILORx Trial |
Contact: Elke Friedman, MD
Kim Sydnor, phone- 288-7159
CALGB/
SWOG
C80405 |
A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum |
Contact: James May, MD
Kim Sydnor, phone- 288-7159
SWOG
S0500 |
A Randomized Phase III Trial to Test the Strategy of Changing Therapy versus Maintaining Therapy for Metastatic Breast Cancer Patients Who Have Elevated Circulating Tumor Cell Levels at First Follow-Up Assessment |
Contact: Charles Welander, MD, 288-8900
Ann Kaplan, RN, phone-287-7418, Beeper 759-4138
GOG
209 |
Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF Versus Carboplatin/Paclitaxel in Patients With Stage III & IV or Recurrent Endometrial Cancer |
GOG
218 |
A Phase III Trial of Carboplatin and Paclitaxel Plus Placebo versus Carboplatin and Paclitaxel Plus concurrent Bevacizu-mab (NSC#704865, IND #7921) followed by Placebo, versus Carboplatin and Paclitaxel Plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed, Previously Untreated Stage III (Suboptimal) and All Stage IV, Epithelial Ovarian or Primary Peitoneal Cancer |
GOG
212 |
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) ( IND #70177), versus No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotheraphy |
GOG
235 |
A Prospective, Longitudinal Study of YKL-40 in Patients with FIGO Stage III or IV Invasive Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Undergoing Primary Chemotherapy |
^ Back to top
Neurology Protocols
Contact: Francis McGee, MD, 288-1972
Jan McGee, phone- 288-1972
| SWISS |
Siblings with Ischemic Stroke Study (SWISS) |
1U01 NS
45719-
01 A1 |
A Multicenter, Double Blind, Randomized Study Comparing the Combined Use of Interferon Beta-la and Glatiramer Acetate to Either Agent Alone in Patients with Relapsing Remitting Multiple Sclerosis (CombiRx-Phase III) |
| 018-01 |
A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery from Middle Cerebral Artery Ischemic Stroke |
^ Back to top
Cardiology Protocols
Contact: Charles Zacharias, MD, 521-5893
Kathleen Turner, RN, phone- 323-5120
| ACT 1 |
Asymptomatic Carotid Stenosis, Stenting vs Endarterectomy Trial |
| Protect |
PROTECTed Carotid Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) |
Sapphire
WW |
Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy |
| CAPTURE 2 |
Carotid Rx Acculink/RX Accunet Post Approval Trial to Uncover Unanticipated or Rare Events |
DURABILI-
TY II |
The US Study for Evaluating Endovascular Treatment of Lesions in the Superficial Femoral Atery and Proximal Popliteal by Using the Protégé EverFlex Stent System II |
Contact: Martin Caplan, MD, 521-5839
Kathleen Turner, Phone 521-5839
PFO
Access
Registry |
PFO Access: Patent Foramen Ovale Closure with the Amplatzer PFO Occluder in Patients with Recurrent Cryptogenic Stroke due to Presumed Paradoxical Embolism through a Patent Ovale who have a Faile Conventional Drug Therapy |
Contact: Sameer Rohatgi, MD
Kathleen Turner, Phone 521-5839
CREATE
PAS
|
Carotid Revascularization with Ev3 Arternial Technology Evolution Post Approval Study |
Contact: Timothy Wolfgang, MD
Margaret Wittenbraker, Phone 569-6100
| AL-208 |
A Phase II Study Designed to Evaluate the Safety, Tolerability, and Effect of a Single, Rising Dose of Intravenous AL-208, followed by a Placebo-Controlled, Double-Blind, Parallel-Group Evaluation of a Single Dose of AL-208, on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery |
Contact: Marc Katz, MD
Diane Wall, Phone 287-7840
Graft
Patency |
Graft Patency Following Minimally Invasive and Robotic CAB with Flex A: A Study Using CT Angiography |
^ Back to top
Orthopaedic Protocols
Contact: John F. Meyers, MD, 527-2800
Sara Pearson, phone- 527-5960 ext. 111
| ORV- ACL |
Two-7 year results of ACL Reconstruction Using Fascia Lata Allograft: Retrospective and Prospective. |
Contact: Paul Kiritsis, MD
Amber Sykes, phone 379-2414
Intra-
medullary Fixation |
The Outcome of Intramedullary Fixation for Displaced Clavicle Fractures |
Contact: Daniel Riddle, PT, PhD, phone 828-0234
Psycho-
logical
Distress |
Prevalence and Impact of Psychological Distress in Patients Prior to and Following Total Knee Replacement Surgery |
Contact: Richard Worland, MD
Shaun Little, PA, phone 270-1405, ext. 6309
Unicom-
partmental
Knee |
Oxford Unicompartmental Knee System Post-Approval Study |
Contact: Richard Worland, MD
Pat Frasher, RN, phone 270-1305
| YM 150 |
A Phase 2b, Double Blind-Double Dummy, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Twice Daily Dosing and Once Daily Dosing YM 150 in Subjects Undergoing Primary Elective Knee Arthroplasty |
Contact: Terry Whipple, MD
Sara Pearson, PhD, phone 527-5960, ext. 111
Ankle
Instability |
An Evaluation of the Safety and Efficacy of Non-Invasive Radiofrequency for the Treatment of Ankle Instability: A Pilot Study |
Contact: William Beach, MD
Sara Pearson, PhD, phone 527-5960, ext. 111
Glider RF
Probe |
A Randomized clinical Trial Compa;ring Knee Themal Chondroplasy Using the Smith & Nephew Glider RF Probe to Debridement Using a Mechanical Shaver |
^ Back to top
Other Protocols
Contact: Marilyn Stern, PhD, 827-0400
Maternal
Adapt
|
Maternal Adaptation to Neonatal Intensive Care Hospitalization and Its
Relationships to Mother-Infant Outcomes |
Contact: Neil Hutcher, M.D.
Barbara Kayes, phone 285-3325
Surgisis
Gold
|
Evaluation of Surgisis Gold Hernia Repair for Prevention of Incisional Hernia After Open Bariatric Surgery |
Contact: Neil Hutcher, M.D.
Irene Zolotorofe, phone 281-8090
BOLD
|
Bariatric Longitudinal Database |
Contact: Kenneth Olshansky, MD, 282-7965
Memory Gel
|
Memory Gel (Post Approval Study) |
Contact: Andrea Pozez, MD
Tina Lucas - Phone: 282-9576
Memory Gel
|
Memory Gel (Post Approval Study) |
Contact: John Edmondson, MD, 272-2411
VUR
|
Randomized Prospective Evaluation of the Incidence of Febrile UTI after Surgical Intervention for PIC Occult Vesicoureteral Reflux |
Contact: Frank Stoneburner, M.D.
Elizabeth Wogen, phone 288-1953
Infrarenal
Stent
|
34 MM Infrarenal Stent Graft Study |
Contact: Marc Warner, M.D.
Melissa Vickery, phone 288-1953
CREATE
PAS
|
Carotid Revascularization with Ev3 Arternial Technology Evolution Post Approval Study |
Contact: Matthew Brengman, M.D.
David Elliott, M.D.
Gregory Shroder, M.D.
Irene Zolotorofe, phone 281-8090
Lap Band
|
A Multi-Center, Open-Label Clinical Evaluation of the Lap-Band AP System in Severely Obese Patients |
Contact: Gregory Shroder, M.D.
Irene Zolotorofe, phone 281-8090
Easy
Band
GOAL
|
Gastric Banding System in Morbidly Obese Patients to Achieve Weight Loss |
Contact: Lori Michener, PT, PhD, phone 828-0234
Effective-
ness of
Rehab
|
Effectiveness of Rehabilitation for Subacromial Impingement Syndrome |
^ Back to top
Nursing Protocols
Contact: Sherry Fox, PhD, 287-7329
Stress
|
Stress and Aging: Caregiver Outcomes in Neuro-oncology |
Contact: Tracy Estes, MS RN, FNP, 764-6310
Exper-
ience
Sampling
|
An Experience Sampling Study of Intrinsic Motivation, Engagement, and Human Well-Being |
Contact: Ann Lass, RN
Ann Kaplan, phone 287-7418, beeper 759-4138
Aroma-
therapy
|
A Randomized Trial of Aromatherapy with Essential Oil of Peppermint in Post-Operative Gynecologic Surgery Patients |
Contact: Ann Kaplan, RN, phone 287-7418
Adher-
ence and
Fatigue
|
A Study of Adherence and Fatigue in a Home Based Exercise Program During or Following Cancer Treatment |
^ Back to top
